| |
|
|
| |
|
 |
 |
¾àǰ°Ë»ö |
 |
ºÎÀÛ¿ë ¹× ´ëó¹ý |
|
|
|
|
|
 |
| |
|
¿ÀºñÁÖ¸£ÁÖ Obizur Inj.
|
Àü¹®ÀǾàǰ | ±Þ¿© | Èñ±ÍÀǾàǰ | ºÐ¾÷¿¹¿ÜÀǾàǰ(45)
|
|
¼öÀÔÀǾàǰ |
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ÀÌ ¾àÀº Èò»öÀÇ µ¿°á°ÇÁ¶ ºÐ¸»ÀÌ ¹«»ö Åõ¸íÇÑ ¹ÙÀ̾˿¡ µç ÁÖ»çÁ¦À̰í, ÷ºÎ¿ëÁ¦´Â ¹«»öÅõ¸íÇÑ ¾×ÀÌ µç ¹«»öÅõ¸íÇÑ À¯¸® ÁÖ»ç±âÀÌ´Ù. ÷ºÎ¿ëÁ¦·Î ³ì¿´À» ¶§ ¹«»öÅõ¸íÇÑ ¾×»ó ÁÖ»çÁ¦°¡ µÈ´Ù. |
|
|
|
|
|
Á¦Á¶È¸»ç |
Çѱ¹´ÙÄÉ´ÙÁ¦¾à(ÁÖ)
|
ÆÇ¸Åȸ»ç |
Çѱ¹´ÙÄÉ´ÙÁ¦¾à(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2023.03.20)
|
BIT ¾àÈ¿ºÐ·ù |
ÁöÇ÷Á¦, Ç÷¾×ÀÀ°íÁ¦ (Hemostatics, Coagulants)
|
º¹ÁöºÎºÐ·ù |
339[±âŸÀÇ Ç÷¾× ¹× ü¾×¿ë¾à ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
696300741 \2,672 ¿ø/500(1)I.U/º´(2024.02.01)(ÇöÀç¾à°¡)
|
|
|
ATCÄÚµå |
Susoctocog alfa / B02BD14 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
¹é´ç,
¼öµ¿½ÄÀǾàǰȥÇÕ¿ë±â±¸,
½ÃÆ®¸£»ê»ï³ªÆ®·ýÀ̼öȹ°,
¿°È³ªÆ®·ý,
¿°ÈÄ®½·À̼öȹ°,
ÁÖ»ç¿ë¼ö,
Æ®¸®½º(È÷µå·Ï½Ã¸ÞÅ»)¾Æ¹Ì³ë¸Þź¼öÈ¿°È¹°,
Æ®¸®½º(È÷µå·Ï½Ã¸ÞÆ¿)¾Æ¹Ì³ë¸Þź,
Æú¸®¼Ò¸£º£ÀÌÆ®80
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2023-11-21 |
|
|
|
|
| |
|
|
|
|